Alternative chelator for ⁸⁹Zr radiopharmaceuticals: radiolabeling and evaluation of 3,4,3-(LI-1,2-HOPO).
Alternative chelator for ⁸⁹Zr radiopharmaceuticals: radiolabeling and evaluation of 3,4,3-(LI-1,2-HOPO).
复制标题
DOI:
10.1021/jm500389b
复制
发表时间:
2014-06-12
影响因子:
7.3
通讯作者:
Francesconi LC
中科院分区:
文献类型:
--
作者:
Deri MA;Ponnala S;Zeglis BM;Pohl G;Dannenberg JJ;Lewis JS;Francesconi LC
Zirconium-89 is an effective radionuclide for antibody-based positron emission tomography (PET) imaging because its physical half-life (78.41 h) matches the biological half-life of IgG antibodies. Desferrioxamine (DFO) is currently the preferred chelator for 89Zr4+; however, accumulation of 89Zr in the bones of mice suggests that 89Zr4+ is released from DFO in vivo. An improved chelator for 89Zr4+ could eliminate the release of osteophilic 89Zr4+ and lead to a safer PET tracer with reduced background radiation dose. Herein, we present an octadentate chelator 3,4,3-(LI-1,2-HOPO) (or HOPO) as a potentially superior alternative to DFO. The HOPO ligand formed a 1:1 Zr-HOPO complex that was evaluated experimentally and theoretically. The stability of 89Zr-HOPO matched or surpassed that of 89Zr-DFO in every experiment. In healthy mice, 89Zr-HOPO cleared the body rapidly with no signs of demetalation. Ultimately, HOPO has the potential to replace DFO as the chelator of choice for 89Zr-based PET imaging agents.
登录
查看更多内容
影响因子:
3.1
作者:
Abou DS;Ku T;Smith-Jones PM
通讯作者:
Smith-Jones PM
影响因子:
4.6
作者:
GLEN, GL;HOARD, JL;SILVERTON, JV
通讯作者:
SILVERTON, JV
影响因子:
4.6
作者:
HOARD, JL;SILVERTON, JV
通讯作者:
SILVERTON, JV
影响因子:
9.3
作者:
Dijkers, Eli C. F.;Kosterink, Jos G. W.;Lub-de Hooge, Marjolijn N.
通讯作者:
Lub-de Hooge, Marjolijn N.
影响因子:
--
作者:
BONDI, A
通讯作者:
BONDI, A